Vertical rib plating for the treatment of slipping rib syndrome.

Bioabsorbable plating Rib hypermobility Slipping rib syndrome Slipping rib syndrome recurrence Slipping ribs Vertical rib plating

Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 20 08 2020
revised: 15 09 2020
accepted: 25 09 2020
pubmed: 1 11 2020
medline: 16 9 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

Slipping rib syndrome (SRS) is a painful condition of hypermobile, detached lower costal cartilages impinging the intercostal nerves. While surgical resection of the cartilaginous rib is reported as definitive treatment, recurrent symptoms are common. We describe the addition of vertical bioabsorbable rib plating to decrease recurrence. An IRB-approved (#17-098), single institution, retrospective chart review was performed for patients who presented with SRS from 2009 to 2019 at a single institution. Descriptive statistics were used to compare patients with and without bioabsorbable vertical plating. A total of 85 patients (71.8% female, mean age 17.7 years) underwent evaluation for SRS. Of the 70 who underwent surgery solely for SRS, 29 (41%) underwent vertical rib plating at initial surgery while 41 (58.6%) did not. Recurrent symptoms developed in 7 (17.1%) unplated patients, while only 1 (3.4%) plated patient had recurrent SRS (which occurred after a motor vehicle crash) (p = 0.0116). Of the 8 with recurrent symptoms, 3 underwent vertical plating at a subsequent operation. Rate of recurrent symptoms after cartilage resection alone for SRS was 17.1%. The addition of vertical rib plating with bioabsorbable plates decreased recurrent symptoms and improved outcomes. II.

Sections du résumé

BACKGROUND BACKGROUND
Slipping rib syndrome (SRS) is a painful condition of hypermobile, detached lower costal cartilages impinging the intercostal nerves. While surgical resection of the cartilaginous rib is reported as definitive treatment, recurrent symptoms are common. We describe the addition of vertical bioabsorbable rib plating to decrease recurrence.
METHODS METHODS
An IRB-approved (#17-098), single institution, retrospective chart review was performed for patients who presented with SRS from 2009 to 2019 at a single institution. Descriptive statistics were used to compare patients with and without bioabsorbable vertical plating.
RESULTS RESULTS
A total of 85 patients (71.8% female, mean age 17.7 years) underwent evaluation for SRS. Of the 70 who underwent surgery solely for SRS, 29 (41%) underwent vertical rib plating at initial surgery while 41 (58.6%) did not. Recurrent symptoms developed in 7 (17.1%) unplated patients, while only 1 (3.4%) plated patient had recurrent SRS (which occurred after a motor vehicle crash) (p = 0.0116). Of the 8 with recurrent symptoms, 3 underwent vertical plating at a subsequent operation.
CONCLUSION CONCLUSIONS
Rate of recurrent symptoms after cartilage resection alone for SRS was 17.1%. The addition of vertical rib plating with bioabsorbable plates decreased recurrent symptoms and improved outcomes.
LEVEL OF EVIDENCE METHODS
II.

Identifiants

pubmed: 33127061
pii: S0022-3468(20)30711-9
doi: 10.1016/j.jpedsurg.2020.09.062
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1852-1856

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Lisa E McMahon (LE)

University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA; Phoenix Children's Hospital, Phoenix, AZ, USA; Mayo Clinical School of Medicine, Phoenix, AZ, USA. Electronic address: lmcmahon@phoenixchildrens.com.

Nicole A Salevitz (NA)

University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA.

David M Notrica (DM)

University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA; Phoenix Children's Hospital, Phoenix, AZ, USA; Mayo Clinical School of Medicine, Phoenix, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH